亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會(huì)員登錄|免費(fèi)注冊(cè)|忘記密碼|管理入口 返回主站||保存桌面|手機(jī)瀏覽|聯(lián)系方式|購(gòu)物車
企業(yè)會(huì)員第1年

湖北海易醫(yī)藥化工有限公司  

沒有填寫主營(yíng)業(yè)務(wù)~~
搜索
新聞中心
  • 暫無(wú)新聞
產(chǎn)品分類
  • 暫無(wú)分類
聯(lián)系方式
  • 聯(lián)系人：李意
  • 電話：027-59702961
  • QQ：1565787100
站內(nèi)搜索
 
榮譽(yù)資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無(wú)鏈接
首頁(yè) > 供應(yīng)產(chǎn)品 > 2,3-吡嗪二酸酐
2,3-吡嗪二酸酐
單價(jià) 面議對(duì)比
詢價(jià) 暫無(wú)
發(fā)貨 湖北武漢市付款后3天內(nèi)
庫(kù)存 1000KG起訂1KG
品牌 2,3-吡嗪二羧酸酐
型號(hào) 4744-50-7
規(guī)格 2,3-吡嗪二酸酐
過期 長(zhǎng)期有效
更新 2012-07-13 16:49
 
詳細(xì)信息
中文名稱: 2,3-吡嗪二酸酐
中文同義詞: 2,3-吡嗪二羧酸酐;呋[3,4-B]吡嗪-5,7-二酮;吡嗪-2,3-二羧酸酐;2,3-吡嗪二酸酐;吡嗪-2,3-羧酸酐;吡嗪-2,3-二羧酸酸酐
英文名稱: 2,3-Pyrazinecarboxylic anhydride
CAS號(hào): 4744-50-7
分子式: C6H2N2O3
分子量: 150.09
EINECS號(hào): 225-260-4
Mol文件: 4744-50-7.mol
©2025 湖北海易醫(yī)藥化工有限公司 版權(quán)所有   技術(shù)支持：化工網(wǎng)   訪問量:7124  
 
主站蜘蛛池模板： | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |